Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects



Rating:

Share or cite this content

Citations should be made in the following way:
G. Thalhammer, E. Eber, B. Oberwaldner, D. Dacar, M. Zach (Graz, Austria). Totally implantable venous access devices in patients with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 1257

Member's Comments

No comment yet.

Related content which might interest you: Experience with totally implantable venous access devices in cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003 Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients Source: Eur Respir J 2004; 23: 430-434 Year: 2004 Imaging for insertion of indwelling venous access devices in patients with cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Candidaemia in cystic fibrosis patients with totally implantable venous access devices is associated with invasive procedures and exacerbation frequency Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Totally implantable central venous access ports for M/XDR-TB treatment Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Evaluation of three devices and one technique for pulmonary drainage in a CF patient Source: Eur Respir J 2006; 28: Suppl. 50, 435s Year: 2006 The use of Pezzer catheter in cases of persistent airleak in advanced cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Effectiveness of mechanical insufflation-exsufflation device in pediatric patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Endovascular stripping as a valuable tool to treat distal occlusions of totally implantable vascular devices in CF Source: Eur Respir J 2005; 26: Suppl. 49, 621s Year: 2005 The use of untunneled indwelling pleural catheters for non-malignant pleural effusions in the outpatient Source: International Congress 2018 – Pleural effusions, infections and tumours Year: 2018 The use of the PleurX catheter in the management of recurrent non-malignant pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Complications of a permanently implanted port system for continuous epoprostenol treatment in pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 597s Year: 2002 Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019 Novel technology in the pleural space: more than just indwelling pleural catheters Source: Eur Respir Monogr 2020; 87: 250-262 Year: 2020 Efficacy and complications of small-bore catheters in the management of malignant pleural effusions Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007 Use of noninvasive mechanical ventilation in patients with cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Impact of a wireless implanted pulmonary artery pressure monitoring system in heart failure patients with comorbid chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Catheter tract metastasis in mesothelioma patients with indwelling pleural catheters Source: International Congress 2018 – Cryobiopsy in interstitial lung disease (ILD) Year: 2018 Non-invasive monitoring of intrapulmonary shunt in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010